Latest News and Press Releases

Daix (France), New York City (New York, Etats-Unis), le 1er octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le...

Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused...

Hepalys Pharma, Inc. est une nouvelle société créée par Catalys Pacific, et dans laquelle Inventiva détient une participation de 30%. Dans le cadre de l’accord de licence exclusif, Inventiva...

Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position.  Under the exclusive licensing agreement, Inventiva will receive a $10 million...

Mash Group Oyj:n saneeraushakemuskäsittely käytiin Helsingin käräjäoikeudessa tiistaina 17.3.2020. Yhtiön saamien tietojen mukaan päätös asiassa annetaan 7.4.2020, eli melkein viisi kuukautta...

The Board of Directors of Mash Group PLC has appointed Mr Risto Illukka, MSc, as Group CEO. Mr Illukka has worked in Mash Group since 2008, including as CEO of the Group’s subsidiary Mash Finance PLC,...

Mash, a fast-growing fintech company and the world-leading payments services provider Ingenico have signed a collaboration agreement to provide Mash’s innovative “pay later” solution to Merchants...

Mash ja Domec ovat tänään kertoneet Italian kauppiaille tarjottavan, innovatiivisen “maksa laskulla”-ratkaisun tarjoavan yhteisyrityksen muodostamisesta. Tämä maksuratkaisu kasvattaa kauppiaiden...

Mash and Domec announced today that they will form a joint venture to provide an innovative “pay later” solution to Merchants across Italy. This payment solution boosts Merchant’s sales, increases...

Customers are flocking to Mash as many lenders are exiting the market, following the law change affecting consumer lending. Mash Group already sees major positive impact on demand as more customers...